Auto Injectors, Pen Injectors and Inhaler Systems

Gubelstrasse 22, , 6300 Zug, Switzerland

SHL provides design, development and manufacturing services for advanced drug delivery systems.

The company’s core competencies comprise services in the fields of medtech and patient care. It works closely with leading biotechnology and pharmaceutical companies to develop drug delivery devices, including compact disposable auto-injectors, reusable pen injectors and complex inhaler systems.

These devices use standard pre-filled syringes and cartridges, as well as novel primary containers.

Research, innovation and design services for drug delivery devices

SHL has always invested significantly in research and development (R&D). This investment has especially intensified over the past ten years, allowing the company to upgrade its broad pipeline of next-generation drug delivery devices.

These innovative devices include advanced reusable and disposable injectors that can be enhanced through digital implementations and can accommodate high-volume and high viscosities.

SHL’s investments have strengthened its support in the advancement of drug development and digital healthcare.

In-house manufacturing of auto-injectors and inhaler systems

SHL manufactures high-quality, high-volume drug delivery devices, and is ranked among the top global producers.

Central to its success is the vertical integration of key manufacturing capabilities to ensure quality and time-to-market.

Developing drug delivery devices in-house allows SHL to customise existing platforms in its pipeline, or develop completely bespoke devices based on the unique requirements for its clients.

Key manufacturing capacities include:

  • Tooling: Advanced in-house tooling centre for drug delivery devices
  • Moulding: Extensive range of moulding solutions
  • Automation: Customised assembly and testing equipment
  • CNC machining: High-precision CNC machining centres
  • Metrology: Precision inspection of product components and equipment parts
  • Assembly: Semi-automatic and fully-automatic assembly solutions

Drug delivery device assembly, labelling and packaging

SHL provides final assembly, labelling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries.

These services were established to streamline the production and distribution processes for SHL’s injection products to improve end-product quality and offer faster time-to-market.

By integrating an additional piece of the supply chain, SHL offers a fully comprehensive experience for its customer’s drug delivery products.

Key abilities include:

  • Device and primary packaging characterisation
  • Final assembly of auto-injectors or pen injectors
  • Labelling and secondary packaging and/or kitting of assembled devices

Commercialisation solutions for medicine delivery devices

SHL’s international team of dedicated professionals ensures that customer expectations are met and final products are delivered at optimum quality and speed.

The company provides a comprehensive range of services, including:

  • Quality systems: International Standardisation Organisation (ISO) 13485 and US Food and Drug Administration (FDA) 21 Code of Federal Regulations (CFR) 820-compliant systems
  • Regulatory and compliance: Support for regulatory lifecycle management
  • Intellectual property (IP): Comprehensive strategy to safeguard SHL IPs
  • Project management: Dedicated professionals to ensure success of customer projects
  • Global supply chain: Scalable storage and customisable global shipping strategies

About SHL

With locations in Taiwan, Sweden, Switzerland, China and the US, SHL’s experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for clients globally.

As the company is determined to provide the most comprehensive range of solutions and services, it maintains all key capabilities and processes in-house to ensure the best quality and time-to-market.

With more than 4,000 staff worldwide, SHL’s organisation consists of several distinct group companies, including:

  • SHL Medical: Designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labelling and packaging services for leading pharmaceutical and biotech companies across the globe
  • SHL Healthcare: Develops and manufactures equipment solutions for home, hospital and long-term care use
  • SHL Technologies: Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

Molly® 2.25

A large volume variation of the classic Molly® auto-injector, the Molly® 2.25 is designed to accommodate fill volumes up to 2.25mL.

Molly® RNS

An ultra-compact auto-injector that is ideal for convenience and portability.


A highly versatile auto-injector that can accommodate a wide range of fill volumes and liquid viscosities.

Rotaject® Technology

A constant-force technology that allows the delivery of highly viscous formulations of up to several hundred centipoise.


A multi-use injector with a 2.25mL glass syringe that is reusable up to 200 times.


A safety syringe designed with an automatic needle guard that allows the needle to be permanently hidden throughout the injection process.


A dual-chamber auto-injector paired with SHL's NIT® (Needle Isolation Technology) and a simple Twist & Mix mechanism.


A cartridge-based auto-injector built with SHL's market-proven NIT® (Needle Isolation Technology), the VSDI® + NIT® is compatible with cartridge volumes from 1.5mL to 3mL.


A cartridge-based solution built with SHL's market-proven Needle Isolation Technology (NIT®).


An adjustable, multi-dose pen injector with a 3mL cartridge. The device includes an advanced reset feature as well as a dial-back dose correction.

Safeguarding User Needs

Despite being founded in an age when medical devices were more about getting the job done than providing optimum patient experience, SHL Group has from the very beginning placed emphasis on users and usability.

Injecting High-Volume, High-Viscosity Drugs

SHL has extensive experience in the parenteral arena. In this article, SHL details its latest offerings in the world of biologics, as well as its partnership with speciality digital healthcare start-up QuiO to develop injectables in the connected healthcare space.

SHL Attends The 2020 PDA in Virtual Fashion

SHL will join the 2020 Parenteral Drug Association’s annual Universe of Pre-Filled Syringes and Injection Devices virtual event with the launch of our virtual experience platform.

SHL Medical Acquires Weibel CDS

SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging.

SHL Joins PODD Conference on 7-8 October

SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) Conference on 7-8 October, showcasing at Booth 24, the Renaissance Boston Waterfront Hotel in Boston.

SHL to Join 2019 Contracting and Outsourcing Conference

SHL will exhibit at the 2019 Contracting and Outsourcing Conference & Tabletop Exhibition on 26 September in New Brunswick, New Jersey. For this two-day conference, the company is set to showcase its quality offerings in final assembly, labelling and packaging at the one-day tabletop exhibition.

SHL Presents ‘The Faster Path to Market’ Webinar

SHL Group has announced it will hold a live webinar to discuss how pharmaceutical companies can leverage a preconfigured device technology to bring their innovative drug formulations to market more efficiently.

SHL Switzerland Office

Gubelstrasse 22,

6300 Zug


+41 413 680 000

No 36 Liufu Rd, Luzhu District

Taoyuan City 338


+88 632 170 303 +88 632 174 928

PO Box 1240, Augustendalsvagen 7

SE-131 28 Nacka Strand


+46 846 218 00 +46 846 248 90

588 Jim Moran Boulevard

Deerfield Beach, FL 33442

United States of America

+1 954 725 2008 +1 954 725 2009

Bld 8, A-6 Tongfuyu Industrial Park

Bu-Chong, Shajing Town, Baoan District



+86 755 8176 9008 +86 755 8176 9322